Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Laboratory Effect of Rivaroxaban Compared to Enoxaparin as Prophylactic Anticoagulant Therapy After Cesarean Section: A Randomized Open-Label Trial

NCT07820670 is registered in ClinicalTrials.gov with Wolfson Medical Center as lead sponsor.

NCT NCT07820670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07820670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Laboratory Effect of Rivaroxaban Compared to Enoxaparin as Prophylactic Anticoagulant Therapy After Cesarean Section: A Randomized Open-Label Trial
Lead sponsor
Wolfson Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2025
Completion date
December 31, 2027
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section surgery, postpartum period, vte (venous thromboembolism)